Want to join the conversation?
$SIG, which competes with $TIF and $FOSL, repurchased $30MM of stock in 3Q16 and $112MM of stock YTD which is ahead of the company's capital allocation plan and within its annual buy back guidance. $SIG has a balance of $154MM in its share repurchase authorization program.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.